Successful anti-cancer immunotherapy is mainly dependent upon the presence and activation of antigen-specific cytotoxic T cells (CTLs) as essential arms in anti-cancer immunity7 and IFN-γ production needed for amplifying T cell responses1. The gene discussed is IFNG; the disease is cancer.